Novartis Compound Spurs Cartilage in Arthritic Mice

Scientists at Novartis AG have discovered a compound that spurred cartilage growth from stem cells to fix damaged joints of mice, a finding that may point to a novel therapy for the arthritis that afflicts most elderly.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.